![]() |
市场调查报告书
商品编码
1946409
鲨烯市场 - 全球产业规模、份额、趋势、机会及预测(按来源、最终用途产业、地区及竞争格局划分,2021-2031年)Squalene Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source, By End User Industry, By Region & Competition, 2021-2031F |
||||||
全球鲨烯市场预计将从 2025 年的 1.8568 亿美元成长到 2031 年的 3.4786 亿美元,复合年增长率达到 11.03%。
鲨烯是一种天然有机三萜类化合物,因其作为疫苗佐剂的有效性和优异的润肤性能,被广泛应用于製药、化妆品和营养保健品行业。市场成长的主要驱动力是消费者对先进抗衰老和保湿护肤品的需求不断增长,以及医疗保健领域对强效免疫增强剂的迫切需求。此外,终端用户产业庞大的商业性规模也进一步强化了这些关键驱动因素,这些产业依赖此类功能性成分来满足日益增长的效能期望。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 1.8568亿美元 |
| 市场规模:2031年 | 3.4786亿美元 |
| 复合年增长率:2026-2031年 | 11.03% |
| 成长最快的细分市场 | 动物性鲨烯 |
| 最大的市场 | 亚太地区 |
然而,市场发展面临一个障碍:鲨鱼来源的鲨烯因其环境和伦理问题而备受诟病,这使得向生物合成或植物来源替代品的过渡既困难又高成本。这种过渡可能导致价格波动和供应链压力,从而限制该成分在註重成本的市场中的使用。儘管有这些营运挑战,但近期市场数据显示,潜在需求依然强劲。根据欧洲化妆品协会(Cosmetics Europe)预测,欧洲个人护理和化妆品市场规模预计将在2023年达到960亿欧元,这凸显了支持角鲨烯等多功能成分广泛应用的巨大经济机会。
全球角鲨烯市场的主要驱动力是消费者对天然和有机个人护理成分日益增长的需求。随着消费者越来越重视符合道德规范的采购方式,製造商正在迅速调整产品线,以永续的生物合成或植物来源替代品取代鲨鱼来源的角鲨烯。这一转变得益于「清洁美容」趋势,该趋势重视有效的皮肤屏障修復成分。专注于皮肤健康的主要企业的财务表现也印证了这一趋势。根据欧莱雅于2024年2月发布的2023年度报告,该公司皮肤科化妆品部门的销售额增长了28.4%,显示市场对含有鲨烯等必需脂质的、经临床验证的护肤产品有着强劲的需求。
此外,鲨烯作为疫苗佐剂的广泛应用,是其在化妆品市场之外的重要驱动因素。鲨烯烯乳化剂在现代疫苗配方中至关重要,尤其是在流感疫苗中,因为它们能够增强免疫反应并减少抗原剂量。随着医疗系统将重点放在完善的免疫接种计划上,这些解决方案的商业性可行性也日益增强。根据CSL有限公司于2024年8月发布的2024年度报告,该公司子公司CSL Seqirus的佐剂流感疫苗FLUAD的销售额成长了14%,凸显了该公司对鲨烯烯类增效剂的高度依赖。这种需求在整个供应链中蔓延,Bloomage Biotech报告称,其2024财年上半年的原材料业务收入增长了11.02%,证实了市场对高品质生物活性成分的稳定需求。
全球鲨烯市场的扩张受到严重阻碍,因为鲨鱼来源的鲨烯在环境和伦理上备受批评。为了满足永续性的要求,生产商面临着从经济实惠的鲨鱼肝油转向生物合成或植物来源替代品的压力。这种转型给供应链带来了巨大压力,并造成价格波动,因为农产品原料的萃取方法复杂,产量受季节性波动的影响。因此,这些符合伦理的替代品生产成本的增加限制了它们在低利润品类中的生存能力,并有效地抑制了其在大众市场的销售量成长。
这种消费者压力为未能适应变化的公司带来了实际的市场风险。根据加拿大化妆品联盟2024年的数据,84%的美国消费者愿意重新包装产品,以确保不含鲨鱼成分。这种对传统采购方式的普遍抵制迫使业内相关人员将资金重新分配到高成本的供应链重组和产品重新设计上,而不是用于市场成长策略。因此,合规相关的财务成本正在减缓鲨烯在竞争激烈的个人护理类别中的整体普及速度。
生物合成发酵技术的商业化正在迅速改变全球鲨烯产业的供应链。随着生产商寻求扩充性、高纯度的替代品来取代易挥发的植物和海洋来源,这项创新能够利用甘蔗等可再生资源稳定生产生物同源角鲨烷,从而降低与季节性橄榄收穫和鲨鱼肝油相关的供应链风险。合成生物学品牌的成功也印证了这种方法的可行性。根据THG于2024年4月发布的2023财年初步财务业绩,该公司旗舰生物技术品牌Biossance自推出以来,全球累计已达约3亿美元,这表明高端护肤市场对发酵衍生角鲨烷有着强劲的商业性需求。
同时,将鲨烯添加到纯素和洁净标示美容产品中正成为一股重要趋势,配方师们积极转向使用无动物实验、经认证的有机成分,以满足消费者的道德需求。这一趋势超越了简单的成分替代,而是拥抱透明的采购通讯协定,力求在所有产品线中消除动物性成分。即使在经济挑战影响自由裁量权支出的情况下,该产业的韧性依然显而易见。根据土壤协会于2024年4月发布的《2024年有机美容与健康市场报告》,经认证的有机市场中的健康和个人护理领域预计将增长6%,这表明消费者持续偏爱使用经过严格检验的植物来源成分(例如植物角鲨烷)的配方。
The Global Squalene Market is projected to expand from USD 185.68 Million in 2025 to USD 347.86 Million by 2031, achieving a CAGR of 11.03%. As a natural organic triterpene, squalene is extensively used in the pharmaceutical, cosmetic, and nutraceutical industries due to its efficacy as a vaccine adjuvant and its superior emollient qualities. Market growth is chiefly driven by rising consumer appetite for advanced anti-aging and hydrating skincare products, alongside the urgent requirement for potent immune-boosting agents in medicine. These primary drivers are bolstered by the vast commercial magnitude of end-use sectors that depend on such functional ingredients to satisfy increasing performance expectations.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 185.68 Million |
| Market Size 2031 | USD 347.86 Million |
| CAGR 2026-2031 | 11.03% |
| Fastest Growing Segment | Animal Based Squalene |
| Largest Market | Asia Pacific |
However, market progression faces a hurdle regarding the intense environmental and ethical criticism of shark-derived squalene, necessitating a difficult and expensive shift toward biosynthetic or plant-based substitutes. This transition introduces price instability and supply chain stress, potentially restricting ingredient usage in cost-conscious markets. Despite these operational difficulties, the fundamental demand remains strong, as illustrated by recent market figures. According to Cosmetics Europe, the European personal care and cosmetics market reached a value of €96 billion in 2023, highlighting the massive economic environment driving the uptake of versatile components like squalene.
Market Driver
A major force driving the global squalene market is the escalating demand for natural and organic personal care ingredients. With consumers emphasizing ethical sourcing, manufacturers are swiftly reformulating their lineups to swap shark-derived squalene for sustainable biosynthetic or plant-based options. This shift is hastened by the "clean beauty" trend, which places a high value on effective skin barrier restoration ingredients. This trajectory is validated by the financial results of leading companies prioritizing active skin health; according to L'Oreal's 2023 Annual Report published in February 2024, their Dermatological Beauty Division recorded a sales surge of 28.4%, demonstrating the market's hunger for clinically proven skincare containing essential lipids like squalene.
Additionally, the expanding use of squalene in vaccine adjuvants acts as a crucial driver, broadening the market's scope beyond cosmetics. Squalene emulsions are vital for modern vaccine formulation, especially for influenza, as they improve immune response while lowering antigen dosage requirements. The commercial viability of these solutions is reinforcing as healthcare systems prioritize robust immunization programs. According to CSL Limited's 'Annual Report 2024' from August 2024, CSL Seqirus noted a 14% sales rise for FLUAD, its adjuvanted influenza vaccine, underlining the dependence on squalene-based enhancements. Reflecting this demand across the supply chain, Bloomage Biotech reported an 11.02% revenue increase in its raw materials business during the first half of 2024, confirming the steady need for premium bioactive ingredients.
Market Challenge
The expansion of the global squalene market is significantly hindered by severe environmental and ethical criticism regarding squalene sourced from sharks. Producers are increasingly forced to move away from economical shark liver oil toward biosynthetic or plant-based options to meet sustainability expectations. This migration induces considerable supply chain strain and price instability, as agricultural raw materials are vulnerable to complex extraction methods and seasonal yield variations. Consequently, the increased production costs linked to these ethical substitutes limit their feasibility in lower-margin categories, effectively restricting volume growth within the wider mass market.
This pressure from consumers creates tangible market risks for businesses that do not adapt. According to Cosmetics Alliance Canada, data from 2024 reveals that 84% of consumers in the United States expressed a willingness to change brands to guarantee their products are free from shark-derived materials. This broad rejection of traditional sourcing compels industry participants to reallocate capital toward expensive supply chain restructuring and reformulation rather than market growth initiatives. As a result, the financial costs associated with compliance retard the overall penetration of squalene within the highly competitive personal care sector.
Market Trends
The supply dynamics of the global squalene industry are being rapidly transformed by the commercialization of biosynthetic fermentation technologies, as producers look for scalable, high-purity substitutes for volatile botanical and marine sources. This technological advancement enables the reliable creation of bio-identical squalane from renewable resources such as sugarcane, thereby reducing supply chain risks linked to seasonal olive crops and shark liver oil. The feasibility of this approach is highlighted by the success of brands rooted in synthetic biology; according to THG's 'Preliminary FY 2023 Results' from April 2024, its flagship biotech brand Biossance has accumulated roughly $300 million in global revenue since its launch, proving the strong commercial demand for fermentation-derived squalane in high-end skincare.
Concurrently, the integration of squalene into vegan and clean label beauty products represents a significant trend, with formulators aggressively shifting toward cruelty-free and certified organic ingredients to meet ethical consumer demands. This movement transcends mere ingredient replacement, prompting entire product ranges to embrace transparent sourcing protocols that eliminate animal-derived components. This sector's resilience is clear even amidst economic challenges impacting discretionary spending. According to the Soil Association's 'Organic Beauty and Wellbeing Market Report 2024' released in April 2024, the Health and Personal Care segment of the certified organic market realized a 6% growth rate, indicating a persistent consumer preference for rigorously verified, plant-based formulations utilizing ingredients like phyto-squalane.
Report Scope
In this report, the Global Squalene Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Squalene Market.
Global Squalene Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: